|
Danish cancer breakthrough
|
3
|
Resverlogix Corp.
|
Oct 14, 2015 10:06PM
|
|
In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease
|
3
|
Resverlogix Corp.
|
May 21, 2021 01:54AM
|
|
Re: Ethics Approval?
|
3
|
Resverlogix Corp.
|
Oct 19, 2021 05:11PM
|
|
Re: ACC 2018 Late Breakers Announce
|
3
|
Resverlogix Corp.
|
Jan 23, 2018 09:16PM
|
|
Presentation is up again
|
3
|
Resverlogix Corp.
|
May 18, 2021 02:19AM
|
|
Re: AHA Late Breaker!
|
3
|
Resverlogix Corp.
|
Sep 21, 2019 01:48AM
|
|
Re: Zenith Epigenetics 1407__ Epicongress Boston July 2014
|
3
|
Resverlogix Corp.
|
May 20, 2015 06:27PM
|
|
RVX PNAS article 1310658110_full
|
3
|
Resverlogix Corp.
|
May 20, 2015 06:45PM
|
|
Re: RVX PNAS article 1310658110_full
|
3
|
Resverlogix Corp.
|
May 20, 2015 06:49PM
|
|
Re: BET inhibition and epilepsy
|
3
|
Resverlogix Corp.
|
Jun 08, 2021 02:58AM
|
|
BioWorld mention
|
3
|
Resverlogix Corp.
|
Mar 25, 2021 11:54PM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 10:33AM
|
|
Re: Colchicine....strong support of inflammation hypothesis
|
3
|
Resverlogix Corp.
|
Sep 10, 2020 12:52AM
|
|
A couple that may be of interest while we wait...
|
3
|
Resverlogix Corp.
|
Aug 09, 2018 08:37AM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
3
|
Resverlogix Corp.
|
Jul 27, 2020 06:39PM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
3
|
Resverlogix Corp.
|
Jul 27, 2020 07:10PM
|
|
Re: New RVX Tweet
|
3
|
Resverlogix Corp.
|
Aug 04, 2020 04:16AM
|
|
Zenith Epigenetics did not respond to invitatations in this one
|
3
|
Zenith Epigenetics
|
May 31, 2021 12:00PM
|
|
Another article. Mechanism related.
|
3
|
Resverlogix Corp.
|
Jun 13, 2022 03:06PM
|
|
Re: Questions for AGM attenders
|
3
|
Resverlogix Corp.
|
Oct 30, 2019 01:01AM
|
